Evidence map›Paper›PMID 33674788›Full record

ArticleNature protocols2021

Culture and analysis of kidney tubuloids and perfused tubuloid cells-on-a-chip.

Linda Gijzen, Fjodor A Yousef Yengej, Frans Schutgens, Marianne K Vormann, Carola M E Ammerlaan, Arnaud Nicolas, Dorota Kurek, Paul Vulto, Maarten B Rookmaaker, Henriette L Lanz and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Enhanced Kidney Targeting and Distribution of Tubuloids During Normothermic Perfusion.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  13. Review
  14. Modulation of the cytoskeleton for cancer therapy.Frontiers in cell and developmental biology · 2025
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Progress and breakthroughs in human kidney organoid research.Biochemistry and biophysics reports · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Linda Gijzen *Mimetas BV, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-3760-6052
Fjodor A Yousef Yengej *Hubrecht Institute-Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
Frans SchutgensHubrecht Institute-Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
Marianne K VormannMimetas BV, Leiden, the Netherlands.
Carola M E AmmerlaanHubrecht Institute-Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.
Arnaud NicolasMimetas BV, Leiden, the Netherlands.
Dorota KurekMimetas BV, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-7168-8944
Paul VultoMimetas BV, Leiden, the Netherlands.
Maarten B RookmaakerDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands.
Henriette L LanzMimetas BV, Leiden, the Netherlands.
Marianne C VerhaarDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-3276-6428
Hans CleversHubrecht Institute-Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands. h.clevers@hubrecht.eu.ORCID http://orcid.org/0000-0002-3077-5582
Mimetas (Netherlands) · NLRoyal Netherlands Academy of Arts and Sciences · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced in vitro kidney models are of great importance to the study of renal physiology and disease. Kidney tubuloids can be established from primary cells derived from adult kidney tissue or urine. Tubuloids are three-dimensional multicellular structures that recapitulate tubular function and have been used to study infectious, malignant, metabolic, and genetic diseases. For tubuloids to more closely represent the in vivo kidney, they can be integrated into an organ-on-a-chip system that has a more physiological tubular architecture and allows flow and interaction with vasculature or epithelial and mesenchymal cells from other organs. Here, we describe a detailed protocol for establishing tubuloid cultures from tissue and urine (1-3 weeks), as well as for generating and characterizing tubuloid cell-derived three-dimensional tubular structures in a perfused microfluidic multi-chip platform (7 d). The combination of the two systems yields a powerful in vitro tool that better recapitulates the complexity of the kidney tubule with donor-specific properties.

Indexed as

Lab-On-A-Chip DevicesPerfusionAdolescentAdultAgedAged, 80 and overAnimalsCell FractionationChildChild, PreschoolElectric ImpedanceFemaleFluorescent DyesHumansInfantKidney TubulesFluorescent DyesMembrane Transport Proteins

Identifiers

PMID33674788
OpenAlexW3133650036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.